InsidersTradesSigma
Follow the Sunshine Heart, Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 20 January 2016 (Attribution). Among the most active insiders: Drayton Claudia. All data is openly available.
Analysts rate Sunshine Heart, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Sunshine Heart, Inc. is a company listed on the XNAS market. It focuses on developing medical devices for the treatment of heart diseases.